Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:12 AM
Study NCT ID:
NCT01423305
Status:
COMPLETED
Last Update Posted:
2011-10-21
First Post:
2011-08-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Pharmacokinetic Study (BF-BLOCK)
Sponsor:
Orion Corporation, Orion Pharma
Organization:
Study Overview
Official Title:
Effect of Charcoal on Gastrointestinal Absorption of Budesonide and Formoterol
Status:
COMPLETED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BF-BLOCK
Brief Summary:
The objective of the study is to assess if charcoal prevents the absorption of budesonide and formoterol via GI track. The assessment will be based on comparing the pharmacokinetic parameter area under the concentration-time curve.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: